4. The Politics of Health

Officials said 3.9 per cent of the 400,413 COVID-19 cases between Dec. 14 and June 26 involved partially vaccinated individuals and 0.4 per cent were in those fully immunized.

Countries without face mask mandates experienced significantly higher COVID-19 deaths per million than countries that enacted mask mandates, investigators report in a new study.

We extend previous studies on the impact of masks on COVID-19 outcomes by investigating an unprecedented breadth and depth of health outcomes, geographical resolutions, types of mask mandates, early versus later waves and controlling for other ...

Mask mandates were linked to slower uptick in COVID-19 deaths in a study analyzing data on 44 countries with a combined population of nearly 1 billion

Notes taken whilst preparing a paper on mask efficacy from Nov to Jan 2022. My previous paper on this was written in April 2020 and published in the Proceedings of the National Academy of Science

Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals. The

Researchers from the California Institute of Technology say the “mosaic-8” vaccine could protect people from other coronaviruses, including SARS and MERS.

Provinces across the country are starting to lift their restrictions and this is how some of the hardest hit ones are faring.

In response to a poll by Research Co., 37 per cent of Canadians reported they were infected themselves, or someone in their household was infected after restrictions lifted.

Bridge Consulting examines the opportunities and challenges ahead for China’s mRNA vaccine industry in the post-COVID era. Having eschewed foreign-made mRNA products from Pfizer/BioNTech and Moderna during the peak of the pandemic in the hope of securing domestic alternatives, China and its sizeable biopharma industry now face a challenging path ahead to catch up to…

China's labs have spent years trying to create an mRNA vaccine - its own shots were less effective.

Having access to an mRNA vaccine will be critical to China’s ongoing COVID response.

Beijing approves the first vaccine of its kind as it looks to jumpstart its flailing economy

Purpose To improve understanding of the barriers and enablers to implementing gender and intersectional analysis during the COVID-19 pandemic in Canada. Methods We conducted a policy document analysis (n = 70) of equity-focused policies of the Canadian government published between March 2020 and August 2023. This analysis was complemented with 16 semi-structured key informant interviews with federal policy actors and leadership of civil society organizations. Results Pandemic policy documents demonstrated multiple commitments to address pandemic related inequities, with key informants describing collaborative approaches to implementing these policies, but also limits in terms of the urgent and diffused nature of pandemic response. Implementation gaps related to accessible information, health services and vaccinations were noted and attributed to a reliance on civil society actors who lacked sufficient and sustainable resources, and the behaviors of priority populations whose capacity to comply was limited by the same inequities the policies sought to address. Conclusion The Canadian federal government made concerted efforts to address the needs of a range of priority populations and equity issue areas within its pandemic response, with mixed results. Having a pre-established framework to guide implementation and related relationships overcame some of the urgency challenges related with pandemic response. However, implementation gaps reflected preexisting inequities shaped by broader economic, social and political systems which were infrequently addressed in pandemic policies. There is a need for greater understanding of policy implementation gaps during emergency and crisis response.

The pandemic created dangerous cracks in public confidence in science, governments and public health.

Tania Bubela and colleagues examine how fragmented responsibilities and accountability for public health data hindered Canada’s pandemic response Canada’s public health system was reformed after its 2003 severe acute respiratory syndrome (SARS) outbreak, which was the worst outside of Asia with 438 cases and 44 deaths.1 Ensuing national and provincial inquiries led to the creation of the national Public Health Agency of Canada (PHAC) to coordinate Canada’s preparation for and response to public health threats.2 Subnational public health agencies were also created or strengthened to function as regional centres for disease control.1 These actions should have put Canada in a good position to respond to the covid-19 pandemic.34 Despite these reforms, Canada experienced serious failures during the covid-19 pandemic. Memories faded rapidly after SARS, and if history is not to repeat itself, government and health system leaders must strengthen the country’s public health and healthcare systems in preparation for the next threat. Health authorities as well as all Canadians need to reflect on the crises of the past three years—what went well and why; what caused pandemic response failures, and what were their consequences? Here, in the first of a series of articles examining Canada’s response and setting out suggestions for a national inquiry, we examine the limitations of the country’s decentralised structure for public health decision making and missed lessons from the 2003 SARS-CoV-1 outbreak, particularly with regard to data infrastructure.5 Other articles in the series examine how research and data failed to inform public health responses tailored to community and population needs,6 the predictable failures in long term care,7 and Canada’s role in global vaccine inequity.8 Canada’s cumulative confirmed covid-19 death rate, as of June 2023, was 1372 per million population, exceeding the global average of 855 per million …

Now is the time to learn from the COVID-19 response through an action-oriented independent inquiry focused on accountability. Reforms to data generation, access and use are essential.

TORONTO - Canada's gynecologists say COVID-19 vaccination "remains safe and strongly recommended" during pregnancy and while breastfeeding.

Recent research provides evidence to back the safety and effectiveness of the COVID-19 vaccine for pregnant women.

Pregnant people with COVID-19 are at increased risk of severe illness and death compared with non-pregnant females of reproductive age (aged 15–49 years).1 Additionally, COVID-19 during pregnancy is associated with increased risk for adverse pregnancy outcomes, such as preterm birth and stillbirth.1 When mRNA COVID-19 vaccines first became available in December, 2020, safety data in pregnancy were limited because pregnant people were excluded from pre-authorisation clinical trials.2 Lack of data and safety concerns contributed to initially low uptake among pregnant people, which continues to be lower than uptake among non-pregnant females of reproductive age.

Rare serious complications have been documented after COVID-19 vaccination as clinical research proceeded and new target populations, such as children and ‎pregnant women, were included. In this study, we attempted to review the literature relevant ...

Existing evidence on the safety and efficacy of getting a COVID vaccine in pregnancy all points the same way: the shot is important for maternal and fetal health.

Pregnant people experienced lower rates of side-effects from the COVID-19 vaccine than their counterparts who weren't pregnant, a new Canadian study suggests.

Viruses like HSV-1 and SARS-CoV-2 might trigger Alzheimer’s disease.

As the masks come off at my daughter’s school — and around the country — I’m worried about COVID’s next move.

Safety data from more than 298 million doses of mRNA COVID-19 vaccine administered in the first 6 months of the US vaccination programme show that most reported adverse events were mild and short in duration.

Medical experts on the basis of evidence so far disagree with claims made on social media that myocarditis following the COVID-19 vaccine is irreversible. Social media claims that “over the years,” many children diagnosed with myocarditis will die are unfounded, representatives from the Myocarditis Foundation say.

What is it like to be pulled into a different world, where only you and a select few can see the truth?

‘Herd immunity is an elusive concept and doesn’t apply to coronavirus,’ says Dr. Don Milton at the University of Maryland School of Public Health.